Data search


search
Exact
Search

Results for MligTC455_09470

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_09470 14 0.29 Mlig455_034931

Neo: -

Age: -

Mlig455_034931 {REF} {Length: 484} {NoTransDecoderORF} {RNA1310_124147}

Cumulative graph for MligTC455_09470

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 - - - -
RegionR2 - - - -
RegionR3 - - - -
RegionR4 - - - -
RegionR5 - - - -
RegionR6 - - - -
RegionR7 - - - -
RegionR8 - - - -

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 - - - -
RegenerationR2 - - - -
RegenerationR3 - - - -
RegenerationR4 - - - -
RegenerationR5 - - - -
RegenerationR6 - - - -
RegenerationBL - - - -
RegenerationTP - - - -


Genes with expression patterns similar to MligTC455_09470

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_09470 14 0.29 Mlig455_034931

Neo: -

Age: -

1 - - - - - 1.000 Mlig455_034931 {REF} {Length: 484} {NoTransDecoderORF} {RNA1310_124147}
2. MligTC455_09224 21 0.43 Mlig455_038078

Neo: -

Age: -

0.996 - - - - - 0.996 Mlig455_038078 {REF} {Length: 771} {Pfam: PAN domain [PF00024.28, score=28.0]} {RNA1509_46267} {RNA1310_51656} {RNA815_32275.1}
3. MligTC455_22469 37 0.77 Mlig455_052705

Neo: -

Age: logFC(26M/2M)=-1.003

GUK1 0.996 - - - - - 0.996 Mlig455_052705 {REF} {Length: 1833} {Pfam: Guanylate kinase [PF00625.23, score=207.7]; AAA domain [PF13671.8, score=35.1]; 50S ribosome-binding GTPase [PF01926.25, score=28.4]; AAA domain [PF13238.8, score=26.9]; ABC transporter [PF00005.29, score=24.3]; AAA ATPase domain [PF13191.8, score=24.0]; AAA domain [PF13401.8, score=23.0]; P-loop containing region of AAA domain [PF13555.8, score=21.3]; RsgA GTPase [PF03193.18, score=20.4]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=19.0]} {Human: ENSG00000143774, GUK1, guanylate kinase 1, [RH, Score=230, Expect=4e-77]} {Mouse: ENSMUSG00000020444, Guk1, guanylate kinase 1, [RH, Score=228, Expect=2e-76]} {Dmel: FBgn0036099, CG11811, [RH, Score=202, Expect=9e-66]} {Celegans: WBGene00020190, guk-1, GUanylate Kinase, [RH, Score=195, Expect=2e-63]} {Smed: dd_Smed_v6_4875_0_1, dd_Smed_v6_4875_0_1, [RH, Score=225, Expect=2e-75]} {RNA1509_30404} {RNA1310_39734} {RNA815_22943.1}
4. MligTC455_01256 9 0.19 Mlig455_019247

Neo: -

Age: -

0.995 - - - - - 0.995 Mlig455_019247 {REF} {Length: 889} {Celegans: WBGene00020795, T25D1.3, [Score=47.4, Expect=2e-07]} {RNA1310_599.2}
5. MligTC455_21502 36 0.75 Mlig455_018529

Neo: -

Age: -

Region-enriched R2: 5.380/0.01311

0.995 - - - - - 0.995 Mlig455_018529 {REF} {Length: 1004} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=43.7]} {Mouse: ENSMUSG00000032463, Faim, Fas apoptotic inhibitory molecule, [Score=54.7, Expect=2e-09]} {Smed: dd_Smed_v6_4798_0_1, dd_Smed_v6_4798_0_1, [RH, Score=75.1, Expect=7e-18]} {RNA1310_42034} {RNA815_19884}
6. MligTC455_19279 4576 95.33 Mlig455_057411

Neo: -

Age: Down-Down-Up, logFC(26M/2M)=-0.654

Region-specific R2: 5.173

Region-enriched R2: 4.585/0.00000
Region-enriched R3: 2.611/0.00003

CHRNA10 0.994 - - - - - 0.994 Mlig455_057411 {REF} {Length: 1075} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1}
7. MligTC455_15327 51 1.07 Mlig455_003799, Mlig455_054316

Neo: -

Age: Down-Up-Down

CPLX1 0.993 - - - - - 0.993

Mlig455_003799 {REF} {Length: 3120} {Pfam: Synaphin protein [PF05835.14, score=100.6]; PVL ORF-50-like family [PF07768.13, score=19.1]} {Human: ENSG00000168993, CPLX1, complexin 1, [RH, Score=55.8, Expect=9e-10]; ENSG00000145920, CPLX2, complexin 2, [RH, Score=54.3, Expect=1e-09]} {Mouse: ENSMUSG00000033615, Cplx1, complexin 1, [Score=57.0, Expect=2e-10]} {Dmel: FBgn0041605, cpx, complexin, [Score=66.2, Expect=9e-14]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [Score=77.8, Expect=2e-18]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=91.7, Expect=6e-24]} {RNA1310_47061}

Mlig455_054316 {REF} {Length: 3045} {Pfam: Synaphin protein [PF05835.14, score=100.6]; PVL ORF-50-like family [PF07768.13, score=19.1]} {Human: ENSG00000168993, CPLX1, complexin 1, [RH, Score=55.8, Expect=9e-10]; ENSG00000145920, CPLX2, complexin 2, [RH, Score=54.3, Expect=1e-09]} {Mouse: ENSMUSG00000033615, Cplx1, complexin 1, [Score=57.0, Expect=2e-10]} {Dmel: FBgn0041605, cpx, complexin, [Score=66.2, Expect=9e-14]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [Score=77.8, Expect=2e-18]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=91.7, Expect=6e-24]} {RNA1310_47061}
8. MligTC455_36959 14 0.28 Mlig455_019348, Mlig455_019567, Mlig455_045238

Neo: -

Age: -

AC243734.1 0.992 - - - - - 0.992

Mlig455_019348 {REF} {Length: 1134}

Mlig455_019567 {REF} {Length: 1135}

Mlig455_045238 {REF} {Length: 1757} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=170.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.4]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=244, Expect=1e-73]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=244, Expect=1e-73]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=243, Expect=5e-73]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=233, Expect=3e-69]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=244, Expect=1e-73]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=235, Expect=2e-70]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=252, Expect=5e-76]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=234, Expect=1e-69]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=242, Expect=2e-72]} {RNA1310_104931} {RNA815_34654}
9. MligTC455_14107 77 1.61 Mlig455_025350, Mlig455_025394

Neo: -

Age: -

Region-enriched R2: 10.212/0.00000
Region-enriched R3: 6.939/0.00014
Region-enriched R5: 4.301/0.02539

0.991 - - - - - 0.991

Mlig455_025350 {REF} {Length: 568} {RNA1310_64375} {RNA815_39588}

Mlig455_025394 {REF} {Length: 749} {RNA1509_58356} {RNA1310_64375} {RNA815_39588}
10. MligTC455_13975 63 1.31 Mlig455_070810

Neo: -

Age: -

Region-enriched R2: 7.513/0.00519

0.989 - - - - - 0.989 Mlig455_070810 {REF} {Length: 1542} {Pfam: Otopetrin [PF03189.15, score=108.9]} {Dmel: FBgn0031514, CG3332, [Score=74.3, Expect=3e-14]} {Celegans: WBGene00015035, otpl-1, OToPetrin-Like, [Score=47.8, Expect=9e-06]} {Smed: dd_Smed_v6_13612_0_3, dd_Smed_v6_13612_0_3, [Score=119, Expect=2e-29]} {RNA1310_93602} {RNA815_48323}
11. MligTC455_43324 71 1.47 Mlig455_041984

Neo: -

Age: -

Region-enriched R2: 6.623/0.00573

0.989 - - - - - 0.989 Mlig455_041984 {REF} {Length: 388} {NoTransDecoderORF} {RNA1509_49821} {RNA1310_52560.2} {RNA815_59873}
12. MligTC455_47393 241 5.03 Mlig455_008718, Mlig455_063579

Neo: -

Age: Down-Up-Down

Region-enriched R2: 3.683/0.00849

CALM2 0.989 - - - - - 0.989

Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211}

Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211}
13. MligTC455_14029 53 1.11 Mlig455_022439

Neo: -

Age: -

0.988 - - - - - 0.988 Mlig455_022439 {REF} {Length: 2874} {RNA1509_36146} {RNA1310_30590} {RNA815_37384}
14. MligTC455_34749 10 0.21 Mlig455_026129

Neo: -

Age: Up-Down-Down

RASGRF2 0.988 - - - - - 0.988 Mlig455_026129 {REF} {Length: 5810} {Pfam: RasGEF domain [PF00617.21, score=176.1]; RhoGEF domain [PF00621.22, score=96.8]; RasGEF N-terminal motif [PF00618.22, score=65.5]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=21.2]} {Human: ENSG00000113319, RASGRF2, Ras protein specific guanine nucleotide releasing factor 2, [Score=506, Expect=3e-158]} {Mouse: ENSMUSG00000032356, Rasgrf1, RAS protein-specific guanine nucleotide-releasing factor 1, [Score=484, Expect=2e-149]} {Dmel: FBgn0001965, Sos, Son of sevenless, [Score=136, Expect=6e-32]} {Celegans: WBGene00004947, sos-1, Son of sevenless homolog, [Score=105, Expect=1e-22]} {Smed: dd_Smed_v6_18313_0_2, dd_Smed_v6_18313_0_2, [Score=747, Expect=0.0]} {RNA1509_15697} {RNA1310_18289} {RNA815_21605.1}
15. MligTC455_36981 59 1.23 Mlig455_050314

Neo: -

Age: -

Region-enriched R2: 4.760/0.03524

ASIC5 0.988 - - - - - 0.988 Mlig455_050314 {REF} {Length: 3328} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=158.3]; Kringle domain [PF00051.20, score=20.5]} {Human: ENSG00000256394, ASIC5, acid sensing ion channel subunit family member 5, [Score=59.3, Expect=2e-08]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=51.6, Expect=3e-06]} {Smed: dd_Smed_v6_16557_0_1, dd_Smed_v6_16557_0_1, [Score=52.8, Expect=6e-07]} {RNA1310_9846.1} {RNA815_21595}
16. MligTC455_23278 386 8.04 Mlig455_037778

Neo: -

Age: logFC(26M/2M)=-0.605

SLC13A3 0.987 - - - - - 0.987 Mlig455_037778 {REF} {Length: 3476} {Pfam: Sodium:sulfate symporter transmembrane region [PF00939.21, score=294.2]; Citrate transporter [PF03600.18, score=99.7]} {Human: ENSG00000158296, SLC13A3, solute carrier family 13 member 3, [Score=377, Expect=4e-121]} {Mouse: ENSMUSG00000018459, Slc13a3, solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3, [Score=367, Expect=1e-117]; ENSMUSG00000001095, Slc13a2, solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2, [Score=359, Expect=9e-115]} {Dmel: FBgn0036816, Indy, I'm not dead yet, [Score=175, Expect=1e-46]} {Celegans: WBGene00007138, B0285.6, Uncharacterized transporter B0285.6, [Score=194, Expect=2e-53]} {Smed: dd_Smed_v6_5476_0_1, dd_Smed_v6_5476_0_1, [Score=315, Expect=3e-98]} {RNA1509_1723, RNA1509_48306} {RNA1310_5497, RNA1509_48306} {RNA1509_48306, RNA815_1709}
17. MligTC455_30159 107 2.22 Mlig455_008465, Mlig455_009916

Neo: -

Age: Up-Down-Down

Region-enriched R2: 4.961/0.00498

TCF7L1 0.987 - - - - - 0.987

Mlig455_008465 {REF} {Length: 2454} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.3]; HMG-box domain [PF09011.12, score=34.6]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=7e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=8e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=4e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=4e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=6e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=4e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=2e-48]} {RNA1310_11181} {RNA815_36690}

Mlig455_009916 {REF} {Length: 2137} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.4]; HMG-box domain [PF09011.12, score=34.7]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=4e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=2e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=157, Expect=5e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=162, Expect=2e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=4e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=3e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=1e-48]} {RNA1310_11181} {RNA815_36690}
18. MligTC455_33636 175 3.64 Mlig455_027209, Mlig455_050659

Neo: -

Age: logFC(26M/2M)=-0.416

Region-enriched R2: 3.904/0.00709
Region-enriched R3: 2.835/0.03879

CHRNA10 0.987 - - - - - 0.987

Mlig455_027209 {REF} {Length: 1614} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=74.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=152, Expect=1e-40]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=150, Expect=8e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=148, Expect=6e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=150, Expect=3e-40]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=150, Expect=5e-40]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=5e-38]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=133, Expect=1e-33]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=142, Expect=3e-37]} {RNA1310_19147.1} {RNA815_8553.1}

Mlig455_050659 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=69.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=144, Expect=1e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=141, Expect=1e-36]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=9e-37]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=134, Expect=4e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=7e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=141, Expect=6e-37]} {RNA1310_19147.1} {RNA815_8553.1}
19. MligTC455_43095 294 6.13 Mlig455_028880

Neo: -

Age: -

Region-enriched R2: 5.606/0.00021

0.987 - - - - - 0.987 Mlig455_028880 {REF} {Length: 822} {RNA1509_32622} {RNA1310_67920, RNA1509_32622} {RNA1509_32622, RNA815_31932.2}
20. MligTC455_16525 20 0.41 Mlig455_051737

Neo: -

Age: -

0.985 - - - - - 0.985 Mlig455_051737 {REF} {Length: 196} {NoTransDecoderORF} {RNA1310_48719} {RNA815_25764}
21. MligTC455_25410 47 0.97 Mlig455_026185

Neo: -

Age: Up-Down-Down

Region-enriched R2: 8.036/0.00469
Region-enriched R6: 6.422/0.01487

0.985 - - - - - 0.985 Mlig455_026185 {REF} {Length: 3002} {Pfam: Variant SH3 domain [PF07653.19, score=19.6]; Growth-arrest specific micro-tubule binding [PF13851.8, score=19.3]} {Mouse: ENSMUSG00000034156, Tspoap1, TSPO associated protein 1, [Score=54.7, Expect=6e-07]} {Smed: dd_Smed_v6_14584_0_1, dd_Smed_v6_14584_0_1, [Score=140, Expect=7e-35]} {RNA1509_45271} {RNA1310_5741} {RNA815_46868}
22. MligTC455_43293 2619 54.57 Mlig455_001393

Neo: -

Age: -

Region-specific R2: 1.579

ANXA7 0.985 - - - - - 0.985 Mlig455_001393 {REF} {Length: 4698} {Pfam: Annexin [PF00191.22, score=268.6]} {Human: ENSG00000138279, ANXA7, annexin A7, [RH, Score=307, Expect=6e-98]} {Mouse: ENSMUSG00000021814, Anxa7, annexin A7, [RH, Score=301, Expect=8e-96]} {Dmel: FBgn0000083, AnxB9, Annexin B9, [Score=259, Expect=4e-82]} {Celegans: WBGene00003589, nex-2, Annexin, [Score=261, Expect=2e-81]} {Smed: dd_Smed_v6_1735_0_1, dd_Smed_v6_1735_0_1, [Score=270, Expect=6e-86]} {RNA1509_5239} {RNA1310_11340, RNA1509_5239} {RNA1509_5239, RNA815_3977}
23. MligTC455_48521 56 1.17 Mlig455_004444

Neo: -

Age: -

0.985 - - - - - 0.985 Mlig455_004444 {REF} {Length: 3968} {Pfam: GDNF/GAS1 domain [PF02351.18, score=19.4]} {Smed: dd_Smed_v6_19517_0_1, dd_Smed_v6_19517_0_1, [RH, Score=111, Expect=3e-25]} {RNA1509_50708} {RNA1310_13399} {RNA815_27009}
24. MligTC455_52746 33 0.7 Mlig455_036774

Neo: -

Age: -

0.985 - - - - - 0.985 Mlig455_036774 {REF} {Length: 1992} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=90.0]} {Smed: dd_Smed_v6_16274_0_1, dd_Smed_v6_16274_0_1, [Score=77.4, Expect=7e-15]} {RNA1310_26715} {RNA815_32348}
25. MligTC455_53224 10 0.21 Mlig455_045944, Mlig455_045972

Neo: -

Age: -

ANGPTL2 0.985 - - - - - 0.985

Mlig455_045944 {REF} {Length: 1327} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=156.2]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=139, Expect=2e-37]; ENSG00000160339, FCN2, ficolin 2, [Score=139, Expect=6e-39]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=138, Expect=5e-37]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=140, Expect=6e-38]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=139, Expect=2e-37]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=135, Expect=2e-36]} {Dmel: FBgn0034160, CG5550, [Score=118, Expect=7e-32]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=117, Expect=2e-29]} {RNA1509_26827} {RNA1310_33619.1} {RNA815_17173.3}

Mlig455_045972 {REF} {Length: 1510} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=156.2]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=139, Expect=2e-37]; ENSG00000160339, FCN2, ficolin 2, [Score=139, Expect=6e-39]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=138, Expect=5e-37]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=140, Expect=6e-38]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=139, Expect=2e-37]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=135, Expect=2e-36]} {Dmel: FBgn0034160, CG5550, [Score=118, Expect=7e-32]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=117, Expect=2e-29]} {RNA1509_26827} {RNA1310_33619.1} {RNA815_17173.3}
26. MligTC455_53414 331 6.9 Mlig455_053442

Neo: -

Age: -

Region-specific R2: 4.308

Region-enriched R2: 3.374/0.00040

RP1 0.985 - - - - - 0.985 Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1}
27. MligTC455_53415 319 6.64 Mlig455_053444

Neo: -

Age: Up-Down-Down

Region-specific R2: 4.862

Region-enriched R2: 4.179/0.00011

RP1 0.985 - - - - - 0.985 Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469}
28. MligTC455_53546 130 2.72 Mlig455_013326, Mlig455_013334

Neo: -

Age: -

Region-enriched R2: 6.753/0.01892

MMP9 0.985 - - - - - 0.985

Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136}

Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136}
29. MligTC455_38775 266 5.54 Mlig455_066758, Mlig455_069705

Neo: -

Age: -

Region-specific R2: 6.147

Region-enriched R2: 5.505/0.02411

WNT6 0.984 - - - - - 0.984

Mlig455_066758 {REF} {Length: 2739} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=9e-15]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=6e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=74.3, Expect=9e-14]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.9, Expect=4e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=71.2, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.2} {RNA815_8552}

Mlig455_069705 {REF} {Length: 2713} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=1e-14]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=7e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=73.9, Expect=1e-13]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.6, Expect=6e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=70.9, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.1, RNA1509_23528} {RNA1509_23528, RNA815_8552}
30. MligTC455_45349 19 0.39 Mlig455_068174

Neo: -

Age: -

0.983 - - - - - 0.983 Mlig455_068174 {REF} {Length: 495} {NoTransDecoderORF}
31. MligTC455_49925 1150 23.95 Mlig455_064457

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=-0.630

Region-enriched R2: 9.768/0.00000

0.983 - - - - - 0.983 Mlig455_064457 {REF} {Length: 2074} {RNA1509_11575, RNA1509_47467, RNA1509_51886, RNA1509_59587} {RNA1310_82147.1, RNA1509_11575, RNA1509_47467, RNA1509_51886, RNA1509_59587} {RNA1509_11575, RNA1509_47467, RNA1509_51886, RNA1509_59587, RNA815_19226.1}
32. MligTC455_10151 146 3.05 Mlig455_068692, Mlig455_068719

Neo: -

Age: -

KREMEN1 0.982 - - - - - 0.982

Mlig455_068692 {REF} {Length: 1086} {Pfam: WSC domain [PF01822.21, score=56.5]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=45.4, Expect=7e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=68.9, Expect=2e-14]} {RNA1310_42686} {RNA815_25047}

Mlig455_068719 {REF} {Length: 1973} {TRANSSPLICED} {Pfam: WSC domain [PF01822.21, score=55.8]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=45.1, Expect=8e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=67.0, Expect=8e-14]} {RNA1509_56630} {RNA1310_42686} {RNA815_25047}
33. MligTC455_33832 112 2.34 Mlig455_029411

Neo: -

Age: Up-Down-Down

Region-enriched R2: 5.300/0.00016
Region-enriched R8: 4.136/0.03070

GLRA3 0.982 - - - - - 0.982 Mlig455_029411 {REF} {Length: 3686} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=3e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=7e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=1e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_35433}
34. MligTC455_36194 30 0.61 Mlig455_064360, Mlig455_064382

Neo: -

Age: -

B3GNT4 0.982 - - - - - 0.982

Mlig455_064360 {REF} {Length: 3119} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=3e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726}

Mlig455_064382 {REF} {Length: 3084} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.4, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=92.0, Expect=9e-20]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726}
35. MligTC455_50566 40 0.84 Mlig455_061499

Neo: -

Age: -

Region-enriched R2: 5.243/0.02447

0.982 - - - - - 0.982 Mlig455_061499 {REF} {Length: 484} {NoTransDecoderORF} {RNA1310_94077} {RNA815_47403}
36. MligTC455_19280 21417 446.19 Mlig455_057387, Mlig455_059547

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.621

Region-enriched R2: 3.570/0.00141

CHRNA10 0.981 - - - - - 0.981

Mlig455_057387 {REF} {Length: 1088} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=87.8]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.5, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=95.5, Expect=4e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=94.0, Expect=2e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=109, Expect=6e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=8e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=97.4, Expect=5e-23]} {RNA1509_1306, RNA1509_1333, RNA1509_15501} {RNA1310_34970, RNA1509_1333, RNA1509_15501} {RNA1509_1333, RNA1509_15501, RNA815_15305.1}

Mlig455_059547 {REF} {Length: 1084} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1}
37. MligTC455_24614 62 1.29 Mlig455_015091, Mlig455_015206

Neo: -

Age: logFC(26M/2M)=-0.441

Region-enriched R4: 7.131/0.00032

Regeneration-downregulated R4: -4.923

Regeneration-depleted R4: -4.923

ECT2 0.981 - - - - - 0.981

Mlig455_015091 {REF} {Length: 3092} {Pfam: RhoGEF domain [PF00621.22, score=124.1]; Domain of unknown function (DUF4795) [PF16043.7, score=21.0]; Winged helix-turn helix [PF13592.8, score=19.5]} {Human: ENSG00000114346, ECT2, epithelial cell transforming 2, [Score=78.6, Expect=2e-14]} {Mouse: ENSMUSG00000020640, Itsn2, intersectin 2, [Score=78.6, Expect=2e-14]; ENSMUSG00000027699, Ect2, ect2 oncogene, [Score=74.7, Expect=2e-13]} {Dmel: FBgn0003041, pbl, pebble, [Score=57.0, Expect=6e-08]} {Celegans: WBGene00002297, ect-2, ECT2 (Mammalian Rho GEF) homolog, [Score=67.0, Expect=3e-11]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [Score=59.7, Expect=5e-09]} {RNA1509_21158} {RNA1310_6370} {RNA815_1845}

Mlig455_015206 {REF} {Length: 3091} {Pfam: RhoGEF domain [PF00621.22, score=124.1]; Domain of unknown function (DUF4795) [PF16043.7, score=21.0]; Winged helix-turn helix [PF13592.8, score=19.5]} {Human: ENSG00000114346, ECT2, epithelial cell transforming 2, [Score=78.6, Expect=2e-14]} {Mouse: ENSMUSG00000020640, Itsn2, intersectin 2, [Score=78.6, Expect=2e-14]; ENSMUSG00000027699, Ect2, ect2 oncogene, [Score=74.7, Expect=2e-13]} {Dmel: FBgn0003041, pbl, pebble, [Score=57.0, Expect=6e-08]} {Celegans: WBGene00002297, ect-2, ECT2 (Mammalian Rho GEF) homolog, [Score=67.0, Expect=3e-11]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [Score=59.7, Expect=5e-09]} {RNA1509_21158, RNA1509_7033} {RNA1310_6370, RNA1509_21158, RNA1509_7033} {RNA1509_21158, RNA1509_7033, RNA815_1845}
38. MligTC455_45861 18 0.38 Mlig455_034439

Neo: -

Age: -

0.981 - - - - - 0.981 Mlig455_034439 {REF} {Length: 1135} {RNA1310_86023}
39. MligTC455_48520 46 0.96 Mlig455_004433

Neo: -

Age: -

0.981 - - - - - 0.981 Mlig455_004433 {REF} {Length: 701} {RNA1310_56623} {RNA815_27009}
40. MligTC455_12367 21 0.43 Mlig455_018415

Neo: -

Age: -

0.98 - - - - - 0.980 Mlig455_018415 {REF} {Length: 1087} {NoTransDecoderORF} {RNA1509_40947} {RNA1310_134428} {RNA815_6067.1}
41. MligTC455_13905 34 0.71 Mlig455_023395

Neo: -

Age: -

0.98 - - - - - 0.980 Mlig455_023395 {REF} {Length: 1110} {Smed: dd_Smed_v6_12856_0_1, dd_Smed_v6_12856_0_1, [Score=47.0, Expect=2e-06]} {RNA1509_18233} {RNA1310_51675} {RNA815_25040}
42. MligTC455_19876 135 2.82 Mlig455_024520, Mlig455_024523

Neo: -

Age: -

0.98 - - - - - 0.980

Mlig455_024520 {REF} {Length: 2352} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744}

Mlig455_024523 {REF} {Length: 2311} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=153, Expect=3e-47]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744}
43. MligTC455_22686 26 0.55 Mlig455_000566, Mlig455_030366

Neo: -

Age: -

GRIK3 0.979 - - - - - 0.979

Mlig455_000566 {REF} {Length: 2943} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=78.1]; Ligand-gated ion channel [PF00060.28, score=52.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=48.7]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=157, Expect=5e-39]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=154, Expect=6e-38]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=154, Expect=7e-38]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=152, Expect=2e-37]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=151, Expect=4e-37]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=150, Expect=4e-37]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=145, Expect=2e-35]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=147, Expect=4e-36]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=137, Expect=4e-33]} {Smed: dd_Smed_v6_22973_0_1, dd_Smed_v6_22973_0_1, [Score=155, Expect=5e-39]} {RNA1310_20394.1} {RNA815_45848}

Mlig455_030366 {REF} {Length: 2933} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=78.1]; Ligand-gated ion channel [PF00060.28, score=51.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=48.7]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=157, Expect=4e-39]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=154, Expect=5e-38]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=152, Expect=2e-37]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=151, Expect=4e-37]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=150, Expect=5e-37]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=150, Expect=4e-37]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=145, Expect=3e-35]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=144, Expect=9e-35]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=147, Expect=5e-36]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=137, Expect=5e-33]} {Smed: dd_Smed_v6_22973_0_1, dd_Smed_v6_22973_0_1, [Score=154, Expect=1e-38]} {RNA1310_20394.1} {RNA815_45848}
44. MligTC455_14830 177 3.68 Mlig455_066372

Neo: -

Age: -

SSUH2 0.978 - - - - - 0.978 Mlig455_066372 {REF} {Length: 1569} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=2e-53]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=1e-40]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=119, Expect=2e-29]} {RNA1509_46058} {RNA1310_5028.1, RNA1509_46058} {RNA1509_46058, RNA815_5650}
45. MligTC455_22688 18 0.37 Mlig455_030413

Neo: -

Age: -

GRIK3 0.978 - - - - - 0.978 Mlig455_030413 {REF} {Length: 3851} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=76.0]; Ligand-gated ion channel [PF00060.28, score=51.9]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=45.7]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=158, Expect=1e-40]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=153, Expect=7e-39]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=149, Expect=7e-38]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=149, Expect=6e-38]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=148, Expect=2e-37]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=142, Expect=1e-35]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=132, Expect=1e-32]} {Smed: dd_Smed_v6_4267_0_3, dd_Smed_v6_4267_0_3, [Score=149, Expect=5e-38]} {RNA1310_20394.1} {RNA815_45848}
46. MligTC455_50172 243 5.05 Mlig455_067182

Neo: -

Age: Down-Up-Up

Region-specific R2: 6.036

Region-enriched R2: 6.524/0.00000

0.978 - - - - - 0.978 Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1}
47. MligTC455_01197 6 0.12 Mlig455_047852

Neo: -

Age: -

0.977 - - - - - 0.977 Mlig455_047852 {REF} {Length: 829} {RNA1509_18414} {RNA1310_42507} {RNA815_19425}
48. MligTC455_09653 51 1.06 Mlig455_044944

Neo: -

Age: -

SLC17A6 0.977 - - - - - 0.977 Mlig455_044944 {REF} {Length: 2769} {Pfam: Major Facilitator Superfamily [PF07690.18, score=118.9]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=260, Expect=4e-79]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=248, Expect=1e-74]} {Mouse: ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=259, Expect=8e-79]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=249, Expect=3e-75]; ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=248, Expect=2e-74]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=223, Expect=1e-64]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=203, Expect=2e-58]} {Smed: dd_Smed_v6_21295_0_1, dd_Smed_v6_21295_0_1, [RH, Score=616, Expect=0.0]} {RNA1310_79790} {RNA815_45443}
49. MligTC455_19277 1013 21.11 Mlig455_059600

Neo: -

Age: -

Region-specific R2: 4.883

Region-enriched R2: 5.766/0.00000
Region-enriched R3: 2.030/0.00976

0.977 - - - - - 0.977 Mlig455_059600 {REF} {Length: 827} {NoTransDecoderORF} {RNA1509_43907} {RNA1310_81348}
50. MligTC455_35895 102 2.12 Mlig455_063971

Neo: -

Age: -

RYK 0.977 - - - - - 0.977 Mlig455_063971 {REF} {Length: 3496} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=209.4]; WIF domain [PF02019.20, score=109.7]; Protein kinase domain [PF00069.27, score=79.1]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=1e-55]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [RH, Score=202, Expect=2e-55]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=239, Expect=4e-69]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [Score=179, Expect=6e-48]} {Smed: dd_Smed_v6_12594_0_2, dd_Smed_v6_12594_0_2, [Score=201, Expect=3e-55]} {RNA1509_58811} {RNA1310_6671.2} {RNA815_41921}
51. MligTC455_45021 381 7.95 Mlig455_046686

Neo: -

Age: Down-Up-Up

Region-enriched R2: 3.428/0.03156

AVP 0.977 - - - - - 0.977 Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813}
52. MligTC455_14829 56 1.17 Mlig455_053237

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=1.599

Region-enriched R2: 3.828/0.03404

SSUH2 0.976 - - - - - 0.976 Mlig455_053237 {REF} {Length: 1420} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=156, Expect=2e-43]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=117, Expect=2e-29]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=87.4, Expect=9e-19]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650}
53. MligTC455_44712 665 13.86 Mlig455_017186

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.471

Region-specific R2: 4.141

Region-enriched R2: 3.536/0.00000

0.976 - - - - - 0.976 Mlig455_017186 {REF} {Length: 1018} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074}
54. MligTC455_48848 282 5.87 Mlig455_005151, Mlig455_021613

Neo: -

Age: -

Region-specific R2: 4.764

Region-enriched R2: 5.813/0.00000

SYT3 0.976 - - - - - 0.976

Mlig455_005151 {REF} {Length: 1574} {Pfam: C2 domain [PF00168.32, score=55.1]} {Human: ENSG00000213023, SYT3, synaptotagmin 3, [Score=68.6, Expect=5e-12]; ENSG00000011347, SYT7, synaptotagmin 7, [Score=67.0, Expect=1e-11]} {Mouse: ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=69.3, Expect=2e-12]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=63.2, Expect=1e-10]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=66.6, Expect=5e-12]} {Smed: dd_Smed_v6_25279_0_1, dd_Smed_v6_25279_0_1, [Score=85.1, Expect=2e-18]} {RNA1310_20857} {RNA815_8396}

Mlig455_021613 {REF} {Length: 1574} {Pfam: C2 domain [PF00168.32, score=55.1]} {Human: ENSG00000213023, SYT3, synaptotagmin 3, [Score=68.6, Expect=5e-12]; ENSG00000011347, SYT7, synaptotagmin 7, [Score=67.0, Expect=1e-11]} {Mouse: ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=69.3, Expect=2e-12]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=63.2, Expect=1e-10]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=66.6, Expect=5e-12]} {Smed: dd_Smed_v6_25279_0_1, dd_Smed_v6_25279_0_1, [Score=85.1, Expect=2e-18]} {RNA1310_20857} {RNA815_8396}
55. MligTC455_14310 27 0.56 Mlig455_021495

Neo: -

Age: -

Regeneration-upregulated R2: 3.309

Regeneration-enriched R2: 3.309

0.975 - - - - - 0.975 Mlig455_021495 {REF} {Length: 4005} {RNA1509_54101} {RNA1310_16857} {RNA815_29628}
56. MligTC455_41285 139 2.89 Mlig455_069278

Neo: -

Age: logFC(26M/2M)=-0.469

Region-enriched R8: 4.794/0.00005
Region-enriched R2: 3.899/0.00664

TRPM7 0.975 - - - - - 0.975 Mlig455_069278 {REF} {Length: 4453} {tRNA: Val(CAC),pseudo, score=20.3} {Pfam: SLOG in TRPM [PF18139.3, score=112.9]; Ion transport protein [PF00520.33, score=47.3]; SLOG in TRPM, prokaryote [PF18171.3, score=33.2]} {Human: ENSG00000092439, TRPM7, transient receptor potential cation channel subfamily M member 7, [Score=280, Expect=3e-76]} {Mouse: ENSMUSG00000027365, Trpm7, transient receptor potential cation channel, subfamily M, member 7, [Score=281, Expect=9e-77]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=292, Expect=1e-81]} {Celegans: WBGene00001796, gtl-2, Gon-Two Like (TRP subfamily), [Score=165, Expect=7e-41]} {Smed: dd_Smed_v6_9288_0_1, dd_Smed_v6_9288_0_1, [Score=411, Expect=1e-123]} {RNA1509_14642} {RNA1310_2379, RNA1509_14642} {RNA1509_14642, RNA815_1069}
57. MligTC455_53413 249 5.2 Mlig455_035022

Neo: -

Age: -

Region-specific R2: 4.451

Region-enriched R2: 3.023/0.00460

RP1 0.975 - - - - - 0.975 Mlig455_035022 {REF} {Length: 5065} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_57003} {RNA1310_2710} {RNA815_13802.1}
58. MligTC455_24536 120 2.5 Mlig455_028895

Neo: -

Age: Up-Down-Down

TRPA1 0.974 - - - - - 0.974 Mlig455_028895 {REF} {Length: 4399} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=276.9]; Ankyrin repeats (many copies) [PF13637.8, score=235.5]; Ankyrin repeats (many copies) [PF13857.8, score=187.3]; Ankyrin repeat [PF00023.32, score=185.3]; Ankyrin repeat [PF13606.8, score=184.2]; Ion transport protein [PF00520.33, score=31.3]} {Human: ENSG00000104321, TRPA1, transient receptor potential cation channel subfamily A member 1, [Score=295, Expect=6e-83]} {Mouse: ENSMUSG00000032769, Trpa1, transient receptor potential cation channel, subfamily A, member 1, [Score=277, Expect=4e-77]} {Dmel: FBgn0035934, TrpA1, Transient receptor potential cation channel A1, [Score=305, Expect=2e-86]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=276, Expect=1e-76]} {Smed: dd_Smed_v6_20683_0_1, dd_Smed_v6_20683_0_1, [RH, Score=551, Expect=2e-178]} {RNA1509_56559} {RNA1310_3837.1} {RNA815_4441}
59. MligTC455_34738 836 17.41 Mlig455_032157, Mlig455_032163, Mlig455_067631

Neo: -

Age: -

0.974 - - - - - 0.974

Mlig455_032157 {REF} {Length: 1841} {Pfam: Stathmin family [PF00836.21, score=49.5]} {Smed: dd_Smed_v6_512_0_1, dd_Smed_v6_512_0_1, [RH, Score=80.5, Expect=2e-21]} {RNA1509_18048, RNA1509_6791} {RNA1310_32272, RNA1509_18048, RNA1509_6791} {RNA1509_18048, RNA1509_6791, RNA815_831}

Mlig455_032163 {REF} {Length: 1001} {Pfam: Stathmin family [PF00836.21, score=44.6]} {Smed: dd_Smed_v6_512_0_1, dd_Smed_v6_512_0_1, [RH, Score=84.0, Expect=3e-22]} {RNA1509_6791} {RNA1310_71333} {RNA815_831}

Mlig455_067631 {REF} {Length: 817} {Pfam: Stathmin family [PF00836.21, score=31.3]} {RNA1509_6791} {RNA1310_71333} {RNA815_831}
60. MligTC455_41153 61 1.28 Mlig455_008928

Neo: -

Age: -

0.974 - - - - - 0.974 Mlig455_008928 {REF} {Length: 2067} {RNA1310_32232} {RNA815_16611}
61. MligTC455_14856 14 0.29 Mlig455_023184

Neo: -

Age: -

ANGPTL7 0.973 - - - - - 0.973 Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1}
62. MligTC455_15253 11 0.22 Mlig455_010266

Neo: -

Age: -

0.973 - - - - - 0.973 Mlig455_010266 {REF} {Length: 252} {NoTransDecoderORF} {RNA815_48483}
63. MligTC455_15598 45 0.94 Mlig455_021461

Neo: -

Age: Down-Up-Up

0.973 - - - - - 0.973 Mlig455_021461 {REF} {Length: 2020} {RNA1310_35982.1} {RNA815_27626}
64. MligTC455_19276 1694 35.28 Mlig455_057303

Neo: -

Age: Down-Down-Up

Region-specific R2: 5.711

Region-enriched R2: 6.117/0.00000
Region-enriched R3: 2.663/0.00058

0.973 - - - - - 0.973 Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171}
65. MligTC455_19278 4335 90.31 Mlig455_057304, Mlig455_070944

Neo: -

Age: logFC(26M/2M)=0.686

Region-specific R2: 5.590

Region-enriched R2: 5.465/0.00000
Region-enriched R3: 2.308/0.00629

CHRNA10 0.973 - - - - - 0.973

Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1}

Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1}
66. MligTC455_24270 71 1.47 Mlig455_005120

Neo: -

Age: -

CHRNA7 0.973 - - - - - 0.973 Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406}
67. MligTC455_38487 21 0.43 Mlig455_035154

Neo: -

Age: -

0.973 - - - - - 0.973 Mlig455_035154 {REF} {Length: 903} {Pfam: WSC domain [PF01822.21, score=52.5]; PAN domain [PF00024.28, score=30.4]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=5e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=50.8, Expect=4e-07]} {RNA1310_44717} {RNA815_43195}
68. MligTC455_45031 6 0.12 Mlig455_018753

Neo: -

Age: -

0.973 - - - - - 0.973 Mlig455_018753 {REF} {Length: 1240} {RNA1509_46869} {RNA1310_21302} {RNA815_22307}
69. MligTC455_50146 37 0.77 Mlig455_050983

Neo: -

Age: -

NPSR1 0.973 - - - - - 0.973 Mlig455_050983 {REF} {Length: 1326} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=105.5]} {Human: ENSG00000187258, NPSR1, neuropeptide S receptor 1, [Score=63.5, Expect=1e-10]} {Mouse: ENSMUSG00000029255, Gnrhr, gonadotropin releasing hormone receptor, [Score=66.6, Expect=4e-12]; ENSMUSG00000044014, Npy5r, neuropeptide Y receptor Y5, [Score=65.5, Expect=3e-11]} {Dmel: FBgn0036278, CrzR, Corazonin receptor, [Score=72.8, Expect=1e-13]} {Celegans: WBGene00013642, daf-38, G-protein coupled receptor daf-38, [Score=65.5, Expect=1e-11]} {Smed: dd_Smed_v6_75337_0_1, dd_Smed_v6_75337_0_1, [Score=66.6, Expect=2e-12]} {RNA1310_64751.2}
70. MligTC455_50389 19 0.39 Mlig455_059799

Neo: -

Age: -

0.973 - - - - - 0.973 Mlig455_059799 {REF} {Length: 1159} {Pfam: LIM domain [PF00412.24, score=54.9]} {Dmel: FBgn0085354, CG34325, [Score=55.1, Expect=6e-09]} {RNA1310_54844} {RNA815_43129}
71. MligTC455_31626 38 0.79 Mlig455_032857

Neo: -

Age: -

SLC23A1 0.972 - - - - - 0.972 Mlig455_032857 {REF} {Length: 2462} {Pfam: Permease family [PF00860.22, score=281.6]} {Human: ENSG00000170482, SLC23A1, solute carrier family 23 member 1, [Score=400, Expect=4e-132]; ENSG00000089057, SLC23A2, solute carrier family 23 member 2, [Score=380, Expect=1e-123]} {Mouse: ENSMUSG00000029847, Slc23a4, solute carrier family 23 member 4, [Score=421, Expect=4e-140]} {Dmel: FBgn0037807, CG6293, [Score=355, Expect=2e-115]} {Celegans: WBGene00008252, C51E3.6, [RH, Score=250, Expect=1e-75]} {Smed: dd_Smed_v6_9401_0_1, dd_Smed_v6_9401_0_1, [RH, Score=304, Expect=9e-96]} {RNA1509_16219} {RNA1310_39982} {RNA815_42063}
72. MligTC455_45020 386 8.05 Mlig455_012422

Neo: -

Age: -

Region-enriched R2: 4.067/0.00066
Region-enriched R3: 2.869/0.01291

AVP 0.972 - - - - - 0.972 Mlig455_012422 {REF} {Length: 1252} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.0]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=50.4, Expect=4e-08]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=52.0, Expect=7e-09]} {RNA1509_50574} {RNA1310_26737, RNA1509_50574} {RNA1509_50574, RNA815_23813}
73. MligTC455_50927 254 5.29 Mlig455_070541, Mlig455_070562

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=-0.296

Region-enriched R2: 7.883/0.00008
Region-enriched R3: 4.441/0.03979

FZD4 0.971 - - - - - 0.971

Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571}

Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571}
74. MligTC455_53860 202 4.22 Mlig455_053523, Mlig455_061000

Neo: -

Age: Up-Down-Down

Region-enriched R2: 3.086/0.02665

RGS3 0.971 - - - - - 0.971

Mlig455_053523 {REF} {Length: 2125} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=9e-51]} {RNA1310_19330.1} {RNA815_18723}

Mlig455_061000 {REF} {Length: 2721} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]; Dehydrin [PF00257.21, score=20.5]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=8e-51]} {RNA1310_19330.1} {RNA815_18723}
75. MligTC455_20560 1006 20.96 Mlig455_005723, Mlig455_059493

Neo: -

Age: logFC(26M/2M)=-0.313

0.97 - - - - - 0.970

Mlig455_005723 {REF} {Length: 3139} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF4537) [PF15057.8, score=42.7]} {Smed: dd_Smed_v6_13233_0_2, dd_Smed_v6_13233_0_2, [Score=90.5, Expect=2e-18]} {RNA1509_23303} {RNA1310_4405.1} {RNA815_9095}

Mlig455_059493 {REF} {Length: 3148} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF4537) [PF15057.8, score=42.7]} {Smed: dd_Smed_v6_13233_0_2, dd_Smed_v6_13233_0_2, [RH, Score=94.4, Expect=1e-19]} {RNA1509_23303} {RNA1310_4405.1, RNA1509_23303} {RNA1509_23303, RNA815_9095}
76. MligTC455_25072 4443 92.56 Mlig455_015899

Neo: -

Age: Down-Down-Down, logFC(26M/2M)=-1.175

Region-enriched R2: 4.389/0.00000

PI16 0.97 - - - - - 0.970 Mlig455_015899 {REF} {Length: 2017} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=112, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=5e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.5, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=5e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_5027} {RNA1310_1356.1} {RNA815_4508}
77. MligTC455_29587 14 0.29 Mlig455_044070

Neo: -

Age: -

0.97 - - - - - 0.970 Mlig455_044070 {REF} {Length: 1365} {RNA1509_26262} {RNA1310_30838} {RNA815_35621}
78. MligTC455_40658 152 3.17 Mlig455_064614

Neo: -

Age: -

CLIP2 0.97 - - - - - 0.970 Mlig455_064614 {REF} {Length: 2460} {Pfam: CAP-Gly domain [PF01302.27, score=60.7]} {Human: ENSG00000106665, CLIP2, CAP-Gly domain containing linker protein 2, [Score=61.6, Expect=2e-09]} {Mouse: ENSMUSG00000063146, Clip2, CAP-GLY domain containing linker protein 2, [Score=62.0, Expect=9e-10]} {Dmel: FBgn0036882, CG9279, [Score=55.1, Expect=9e-08]} {Smed: dd_Smed_v6_12985_0_1, dd_Smed_v6_12985_0_1, [Score=56.2, Expect=2e-08]} {RNA1310_20676} {RNA815_40746}
79. MligTC455_41399 147 3.07 Mlig455_028472, Mlig455_028497

Neo: -

Age: -

Region-enriched R4: 3.401/0.01137

FADS2 0.97 - - - - - 0.970

Mlig455_028472 {REF} {Length: 2155} {Pfam: Fatty acid desaturase [PF00487.26, score=111.7]} {Human: ENSG00000134824, FADS2, fatty acid desaturase 2, [Score=348, Expect=8e-118]; ENSG00000149485, FADS1, fatty acid desaturase 1, [Score=339, Expect=4e-115]} {Mouse: ENSMUSG00000024665, Fads2, fatty acid desaturase 2, [Score=357, Expect=4e-121]} {Celegans: WBGene00001395, fat-3, Delta(6)-fatty-acid desaturase fat-3, [Score=107, Expect=1e-26]} {Smed: dd_Smed_v6_10869_0_1, dd_Smed_v6_10869_0_1, [Score=418, Expect=1e-145]} {RNA1509_26943} {RNA1310_8517.1} {RNA815_15928}

Mlig455_028497 {REF} {Length: 2199} {TRANSSPLICED} {Pfam: Fatty acid desaturase [PF00487.26, score=113.5]; Cytochrome b5-like Heme/Steroid binding domain [PF00173.30, score=60.8]} {Human: ENSG00000134824, FADS2, fatty acid desaturase 2, [Score=409, Expect=5e-140]; ENSG00000149485, FADS1, fatty acid desaturase 1, [Score=402, Expect=3e-136]} {Mouse: ENSMUSG00000024665, Fads2, fatty acid desaturase 2, [Score=422, Expect=4e-145]} {Dmel: FBgn0264294, Cyt-b5, Cytochrome b5, [Score=47.0, Expect=3e-06]} {Celegans: WBGene00001395, fat-3, Delta(6)-fatty-acid desaturase fat-3, [Score=121, Expect=4e-30]} {Smed: dd_Smed_v6_10869_0_1, dd_Smed_v6_10869_0_1, [RH, Score=476, Expect=3e-167]} {RNA1509_26943} {RNA1310_8517.1} {RNA815_15928}
80. MligTC455_44578 12 0.24 Mlig455_048995

Neo: Int S/G2/M

Age: -

Region-enriched R2: 5.730/0.04221

0.97 - - - - - 0.970 Mlig455_048995 {REF} {Length: 2090} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=110.0]} {RNA1310_22174} {RNA815_24783}
81. MligTC455_54199 49 1.01 Mlig455_034715, Mlig455_067590

Neo: -

Age: -

Region-enriched R4: 5.064/0.03900

Regeneration-downregulated R4: -6.361

Regeneration-depleted R4: -6.361

0.97 - - - - - 0.970

Mlig455_034715 {REF} {Length: 5399} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=41.4]} {Smed: dd_Smed_v6_16515_0_1, dd_Smed_v6_16515_0_1, [Score=94.4, Expect=2e-21]} {RNA1310_64595} {RNA815_44335}

Mlig455_067590 {REF} {Length: 3463} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=27.2]} {Smed: dd_Smed_v6_20712_0_1, dd_Smed_v6_20712_0_1, [Score=74.3, Expect=5e-15]} {RNA1310_64595} {RNA815_44335}
82. MligTC455_08837 2734 56.96 Mlig455_047253, Mlig455_047306

Neo: -

Age: -

Region-specific R2: 4.689

Region-enriched R2: 4.490/0.00000
Region-enriched R3: 1.490/0.03544

0.969 - - - - - 0.969

Mlig455_047253 {REF} {Length: 3106} {TRANSSPLICED} {Pfam: Pancreatic hormone peptide [PF00159.20, score=46.0]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [Score=41.6, Expect=3e-06]} {RNA1509_19067, RNA1509_27231} {RNA1310_388.2, RNA1509_19067} {RNA1509_19067, RNA815_3901}

Mlig455_047306 {REF} {Length: 3098} {Pfam: Pancreatic hormone peptide [PF00159.20, score=46.0]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [Score=42.0, Expect=2e-06]} {RNA1509_27231} {RNA1310_388.2, RNA1509_27231} {RNA1509_27231, RNA815_3901}
83. MligTC455_13030 30 0.63 Mlig455_030520

Neo: -

Age: -

0.969 - - - - - 0.969 Mlig455_030520 {REF} {Length: 3950} {RNA1509_41925} {RNA1310_32300.1, RNA1509_41925} {RNA1509_41925, RNA815_29217}
84. MligTC455_16208 38 0.8 Mlig455_060360

Neo: -

Age: -

FCN2 0.969 - - - - - 0.969 Mlig455_060360 {REF} {Length: 1127} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=136.3]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=118, Expect=7e-31]; ENSG00000085265, FCN1, ficolin 1, [Score=117, Expect=3e-30]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=116, Expect=6e-30]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=111, Expect=5e-27]} {Dmel: FBgn0034160, CG5550, [Score=109, Expect=6e-28]} {Celegans: WBGene00020516, T15B7.1, [Score=52.4, Expect=1e-07]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=96.3, Expect=5e-22]} {RNA1310_68891}
85. MligTC455_19079 218 4.54 Mlig455_008746, Mlig455_008760

Neo: -

Age: Down-Up-Up

Region-specific R2: 6.705

Region-enriched R2: 6.864/0.00152

0.969 - - - - - 0.969

Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524}

Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524}
86. MligTC455_30335 45 0.94 Mlig455_000285

Neo: -

Age: -

Regeneration-upregulated R2: 5.587

Regeneration-enriched R2: 5.587

0.969 - - - - - 0.969 Mlig455_000285 {REF} {Length: 371} {Pfam: Integrase core domain [PF00665.28, score=26.9]} {Smed: dd_Smed_v6_11155_0_6, dd_Smed_v6_11155_0_6, [Score=56.6, Expect=2e-11]} {RNA1509_14877} {RNA1310_28454.1} {RNA815_5959.1}
87. MligTC455_32366 22 0.45 Mlig455_034995, Mlig455_056739

Neo: -

Age: -

KREMEN2 0.969 - - - - - 0.969

Mlig455_034995 {REF} {Length: 838} {Pfam: WSC domain [PF01822.21, score=57.3]; PAN domain [PF00024.28, score=30.2]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=48.9, Expect=2e-06]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.1, Expect=7e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=64.7, Expect=6e-12]} {RNA1310_90615} {RNA815_32019}

Mlig455_056739 {REF} {Length: 3691} {RNA1310_90615} {RNA815_24291.1}
88. MligTC455_44177 70 1.46 Mlig455_022828, Mlig455_022920

Neo: -

Age: -

TNKS 0.969 - - - - - 0.969

Mlig455_022828 {REF} {Length: 1654} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=58.3]; Ankyrin repeats (many copies) [PF13637.8, score=51.4]; Ankyrin repeats (many copies) [PF13857.8, score=43.5]; Ankyrin repeat [PF00023.32, score=38.9]; Ankyrin repeat [PF13606.8, score=35.6]} {Dmel: FBgn0039955, CG41099, [Score=56.6, Expect=5e-08]} {Celegans: WBGene00001411, fem-1, Sex-determining protein fem-1, [Score=53.1, Expect=4e-07]} {Smed: dd_Smed_v6_11252_0_1, dd_Smed_v6_11252_0_1, [Score=50.8, Expect=1e-06]} {RNA1509_39040} {RNA1310_886.1} {RNA815_14632}

Mlig455_022920 {REF} {Length: 1424} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=65.4]; Ankyrin repeats (3 copies) [PF12796.9, score=61.1]; Ankyrin repeats (many copies) [PF13857.8, score=57.9]; Ankyrin repeat [PF13606.8, score=50.1]; Ankyrin repeat [PF00023.32, score=49.7]} {Human: ENSG00000173273, TNKS, tankyrase, [Score=56.2, Expect=9e-08]; ENSG00000236759, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000238134, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000285372, AC270292.3, tankyrase, [Score=55.5, Expect=2e-07]; ENSG00000232045, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000206376, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000227333, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000204371, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000224143, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=54.3, Expect=3e-07]; ENSG00000029534, ANK1, ankyrin 1, [Score=53.5, Expect=8e-07]} {Mouse: ENSMUSG00000096265, 4930467E23Rik, RIKEN cDNA 4930467E23 gene, [Score=56.6, Expect=3e-08]; ENSMUSG00000074449, Gm15319, predicted gene 15319, [Score=56.6, Expect=3e-08]; ENSMUSG00000095294, Gm21119, predicted gene, 21119, [Score=56.2, Expect=3e-08]; ENSMUSG00000031529, Tnks, tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase, [Score=56.2, Expect=6e-08]; ENSMUSG00000013787, Ehmt2, euchromatic histone lysine N-methyltransferase 2, [Score=55.1, Expect=2e-07]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=55.1, Expect=2e-07]; ENSMUSG00000110591, Gm31371, predicted gene, 31371, [Score=54.3, Expect=8e-08]; ENSMUSG00000107280, Gm9495, predicted gene 9495, [Score=53.9, Expect=2e-07]; ENSMUSG00000106824, Gm7697, predicted gene 7697, [Score=53.9, Expect=2e-07]} {Dmel: FBgn0040752, Prosap, [Score=58.5, Expect=1e-08]} {Celegans: WBGene00001411, fem-1, Sex-determining protein fem-1, [Score=51.6, Expect=9e-07]} {Smed: dd_Smed_v6_2072_0_20, dd_Smed_v6_2072_0_20, [Score=59.3, Expect=3e-09]} {RNA1509_39040} {RNA1310_19494} {RNA815_14632}
89. MligTC455_45769 79 1.65 Mlig455_018116

Neo: -

Age: -

0.969 - - - - - 0.969 Mlig455_018116 {REF} {Length: 3312} {Pfam: NACHT domain [PF05729.14, score=33.6]; AAA ATPase domain [PF13191.8, score=25.1]; AAA domain [PF13401.8, score=19.4]} {Smed: dd_Smed_v6_9074_0_1, dd_Smed_v6_9074_0_1, [Score=138, Expect=2e-33]} {RNA1509_44893} {RNA1310_38241} {RNA815_33748}
90. MligTC455_11963 43 0.9 Mlig455_038882

Neo: -

Age: -

0.968 - - - - - 0.968 Mlig455_038882 {REF} {Length: 1749} {RNA1310_40220} {RNA815_27849}
91. MligTC455_31696 99 2.06 Mlig455_054925

Neo: -

Age: Down-Down-Up

0.968 - - - - - 0.968 Mlig455_054925 {REF} {Length: 1987} {RNA1310_24838} {RNA815_18727}
92. MligTC455_43322 67 1.4 Mlig455_032888

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=-0.946

Region-enriched R2: 7.587/0.00001

0.968 - - - - - 0.968 Mlig455_032888 {REF} {Length: 2179} {RNA1509_40507, RNA1509_49821} {RNA1310_22780, RNA1509_40507} {RNA1509_40507, RNA815_9762}
93. MligTC455_44176 89 1.85 Mlig455_022911

Neo: -

Age: -

TNKS 0.968 - - - - - 0.968 Mlig455_022911 {REF} {Length: 1883} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=67.0]; Ankyrin repeats (3 copies) [PF12796.9, score=64.6]; Ankyrin repeats (many copies) [PF13857.8, score=59.2]; Ankyrin repeat [PF13606.8, score=50.9]; Ankyrin repeat [PF00023.32, score=50.1]} {Human: ENSG00000173273, TNKS, tankyrase, [Score=57.8, Expect=3e-08]; ENSG00000285372, AC270292.3, tankyrase, [Score=56.6, Expect=7e-08]; ENSG00000236759, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000238134, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000204371, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000206376, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000227333, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000232045, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000224143, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000029534, ANK1, ankyrin 1, [Score=55.5, Expect=2e-07]} {Mouse: ENSMUSG00000095294, Gm21119, predicted gene, 21119, [Score=57.8, Expect=1e-08]; ENSMUSG00000096265, 4930467E23Rik, RIKEN cDNA 4930467E23 gene, [Score=57.8, Expect=1e-08]; ENSMUSG00000031529, Tnks, tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase, [Score=57.8, Expect=2e-08]; ENSMUSG00000074449, Gm15319, predicted gene 15319, [Score=57.4, Expect=1e-08]; ENSMUSG00000013787, Ehmt2, euchromatic histone lysine N-methyltransferase 2, [Score=55.8, Expect=9e-08]; ENSMUSG00000063932, Poteg, POTE ankyrin domain family, member G, [Score=55.5, Expect=8e-08]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=55.5, Expect=1e-07]; ENSMUSG00000110591, Gm31371, predicted gene, 31371, [Score=55.5, Expect=4e-08]; ENSMUSG00000106824, Gm7697, predicted gene 7697, [Score=55.1, Expect=8e-08]; ENSMUSG00000107280, Gm9495, predicted gene 9495, [Score=55.1, Expect=8e-08]} {Dmel: FBgn0040752, Prosap, [Score=58.9, Expect=6e-09]} {Celegans: WBGene00001411, fem-1, Sex-determining protein fem-1, [Score=53.5, Expect=2e-07]} {Smed: dd_Smed_v6_2072_0_22, dd_Smed_v6_2072_0_22, [Score=62.0, Expect=4e-10]} {RNA1509_39040} {RNA1310_19494} {RNA815_14632}
94. MligTC455_48064 23 0.48 Mlig455_061550

Neo: -

Age: -

0.968 - - - - - 0.968 Mlig455_061550 {REF} {Length: 860} {RNA1310_88363} {RNA815_47885}
95. MligTC455_33637 187 3.9 Mlig455_027211, Mlig455_027458

Neo: -

Age: -

Region-enriched R2: 3.458/0.04514

CHRNA10, CHRNA7 0.967 - - - - - 0.967

Mlig455_027211 {REF} {Length: 782} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=89.4, Expect=4e-20]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=89.4, Expect=4e-20]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=2e-20]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=1e-20]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=92.0, Expect=4e-21]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=81.6, Expect=9e-18]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=71.6, Expect=2e-14]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=86.3, Expect=1e-19]} {RNA1310_19147.2} {RNA815_8553.2}

Mlig455_027458 {REF} {Length: 1493} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=149, Expect=1e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=133, Expect=5e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=6e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=144, Expect=7e-38]} {RNA1310_19147.2} {RNA815_8553.2}
96. MligTC455_44209 764 15.92 Mlig455_011059

Neo: -

Age: -

EGR1 0.967 - - - - - 0.967 Mlig455_011059 {REF} {Length: 2031} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=54.2]; Zinc-finger double domain [PF13465.8, score=48.5]; C2H2-type zinc finger [PF13894.8, score=44.8]; C2H2-type zinc finger [PF13912.8, score=32.9]} {Human: ENSG00000120738, EGR1, early growth response 1, [RH, Score=159, Expect=1e-43]; ENSG00000179388, EGR3, early growth response 3, [RH, Score=155, Expect=2e-43]; ENSG00000122877, EGR2, early growth response 2, [RH, Score=154, Expect=6e-42]} {Mouse: ENSMUSG00000038418, Egr1, early growth response 1, [RH, Score=159, Expect=9e-44]; ENSMUSG00000033730, Egr3, early growth response 3, [RH, Score=155, Expect=2e-43]; ENSMUSG00000116458, Egr2, early growth response 2, [RH, Score=154, Expect=3e-42]; ENSMUSG00000037868, Egr2, early growth response 2, [RH, Score=154, Expect=3e-42]} {Dmel: FBgn0003499, sr, stripe, [RH, Score=163, Expect=5e-44]} {Celegans: WBGene00007772, egrh-1, EGR (Early Growth factor Response factor) Homolog, [RH, Score=153, Expect=3e-42]} {Smed: dd_Smed_v6_7091_0_1, dd_Smed_v6_7091_0_1, [RH, Score=136, Expect=1e-36]} {RNA1509_16885, RNA1509_28595} {RNA1310_14689, RNA1509_16885, RNA1509_28595} {RNA1509_16885, RNA1509_28595, RNA815_10071.1}
97. MligTC455_44328 858 17.88 Mlig455_026172

Neo: -

Age: Down-Up-Up

Region-specific R2: 4.714

Region-enriched R2: 4.385/0.00000

0.967 - - - - - 0.967 Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486}
98. MligTC455_08277 39 0.81 Mlig455_015604

Neo: -

Age: -

PAQR8 0.966 - - - - - 0.966 Mlig455_015604 {REF} {Length: 1803} {Pfam: Haemolysin-III related [PF03006.22, score=71.6]} {Human: ENSG00000170915, PAQR8, progestin and adipoQ receptor family member 8, [Score=82.0, Expect=8e-17]} {Mouse: ENSMUSG00000025931, Paqr8, progestin and adipoQ receptor family member VIII, [Score=86.3, Expect=2e-18]} {Dmel: FBgn0038256, CG7530, [Score=50.8, Expect=7e-07]} {Celegans: WBGene00019643, K11C4.2, [Score=62.8, Expect=6e-11]} {Smed: dd_Smed_v6_14141_0_1, dd_Smed_v6_14141_0_1, [Score=65.5, Expect=9e-12]} {RNA1509_10181} {RNA1310_17206} {RNA815_6661}
99. MligTC455_14831 280 5.83 Mlig455_067864

Neo: -

Age: Up-Down-Up

Region-enriched R2: 3.261/0.00352

SSUH2 0.966 - - - - - 0.966 Mlig455_067864 {REF} {Length: 1575} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=6e-54]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=7e-41]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=118, Expect=1e-29]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650}
100. MligTC455_16875 42 0.88 Mlig455_028243

Neo: -

Age: Up-Down-Down

KCNK16 0.966 - - - - - 0.966 Mlig455_028243 {REF} {Length: 2676} {Pfam: Ion channel [PF07885.18, score=116.8]; Ion transport protein [PF00520.33, score=28.8]; Protein of unknown function (DUF3112) [PF11309.10, score=19.5]} {Human: ENSG00000095981, KCNK16, potassium two pore domain channel subfamily K member 16, [Score=97.8, Expect=5e-22]; ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=97.4, Expect=2e-21]; ENSG00000100433, KCNK10, potassium two pore domain channel subfamily K member 10, [Score=94.4, Expect=6e-20]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=102, Expect=4e-23]; ENSMUSG00000023387, Kcnk16, potassium channel, subfamily K, member 16, [Score=98.2, Expect=2e-22]} {Dmel: FBgn0033257, sand, sandman, [Score=150, Expect=2e-40]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=162, Expect=5e-45]} {Smed: dd_Smed_v6_17586_0_1, dd_Smed_v6_17586_0_1, [Score=340, Expect=2e-113]} {RNA1509_39975} {RNA1310_18301.1, RNA1509_39975} {RNA1509_39975, RNA815_12440}

There are 101 more genes with r >= 0.95  Show all


Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA